Drug survival is superior among patients treated with guselkumab compared to adalimumab in the voyage 1 trial Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Pariser, D.; Wu, J.; Strober, B.; Bagel, J.; Song, M.; Shen, Y.; Langholff, W.; Lin, R.; Srivastava, B.; Griffiths, C.

publication date

  • May 1, 2019


published in


start page

  • 44

end page

  • 45


  • 60